1. Date Stock price How it’s affected
17.Feburary
2020
4.76 EGP This meeting affects the stock as
it reverses its growth by lightly
reduction (0.05)
23.November
2020
(Annual board
meeting report)
4.02 EGP This meeting affects the stock as
it reverses its growth by lightly
reduction (0.07)
23.March
2020
3.27 EGP No effect
10.May
2020
3.15 EGP No effect
17.May
2020
3.04 EGP it affects negatively on the firm
as it decreased its stock price
as it decreased by 2.47%

2. 23.June
2020
(Manufacturing the drug
“Invisiram”, to use it in the
treatment of people infected
with the (Covid-19) virus.)
3.42 EGP it affects positively on the firm
as it increased its stock price
as it increased by 20.60%
20.July
2020
(Research unit of the
investment bank “Belton”
covered the share of the Tenth
of Ramadan Company for
Pharmaceutical Industries and
Diagnostic Products – Rameda
– and recommended investors
to buy the share)
2.85 EGP it affects positively on the firm
as it increased its stock price
as it increased by 2.77%
13.August
2020
3.07 EGP it affects negatively on the firm
as it decreased its stock price
as it decreased by 1.23%
14.October
2020
2.81 EGP it affects positively on the firm
as it increased its stock price
as it increased by 0.28%
9.November
2020
2.84 EGP it affects positively on the firm
as it increased its stock price
as it increased by 1.93%
22.December
2020
(The investment bank “Belton”
research unit choose 12 stocks listed
on the Egyptian Stock Exchange, to
be the best out of 47 stocks under its
coverage during 2021, with an
average potential increase of 48%
and one of these stocks is rameda)
2.75 EGP it affects positively on the firm
as it increased its stock price
as it increased by 1.42%

3. 21.March
2021
2.27 EGP it affects negatively on the firm
as it decreased its stock price
as it decreased by 0.67%
18.April
2021
2.06 EGP it affects positively on the firm
as it increased its stock price
as it increased by 5.93%
6.May
2021
2.11 EGP it affects positively on the firm
as it increased its stock price
as it increased by 1.86%
24.August
2021
2.21 EGP it affects positively on the firm
as it increased its stock price
as it increased by 1.41%
8.October
2021
1.93 EGP it affects negatively on the firm
as it decreased its stock price
as it decreased by 2.42%
25.November
2021
(Annual board
meeting report)
2.23 EGP it affects positively on the firm
as it increased its stock price
as it increased by 5.69%

4. References:
https://ramedapharma-ir.com/en/board-and-shareholders-actions#tab_msbod-
reports-and--resolutions (rameda.com)
https://www.investing.com/equities/tenth-of-ramadan-for-pharmaceutical-
historical-data (investing.com)
https://almalnews.com/search/?term=%20%D8%B3%D9%87%D9%85%20
%D8%B1%D8%A7%D9%85%D9%8A%D8%AF%D8%A7
. (almalnews.com)